UC Davis MIND Institute
Welcome,         Profile    Billing    Logout  
 21 Trials 
43 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hendren, Robert L
NCT02649959: An Open Label Study of CM-AT for the Treatment of Children With Autism

Active, not recruiting
3
405
US
CM-AT
Curemark
Autism
01/25
01/25
NCT05081245: ML-004 in Adolescents and Adults with Autism Spectrum Disorders (ASD)

Recruiting
2
150
Canada, US, RoW
ML-004 (IR)/(ER) tablet, ML-004 Placebo
MapLight Therapeutics
Autism Spectrum Disorder
03/25
04/25
Ramos, Juan Carlos
PEGASUS, NCT02799706: Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

Active, not recruiting
3
885
Europe
Degarelix, approved GnRH agonist, Radiotherapy
European Organisation for Research and Treatment of Cancer - EORTC
Prostate Cancer
08/23
06/26
OASIS, NCT05101187: Olorofim Aspergillus Infection Study

Recruiting
3
225
Europe, Canada, Japan, US, RoW
Olorofim, Olorofim (F901318), AmBisome®, AmBisome® (liposomal amphotericin B)
F2G Biotech GmbH, Iqvia Pty Ltd, Shionogi
Invasive Aspergillosis
09/25
11/26
V-PLAQUE, NCT05360446: Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

Active, not recruiting
3
608
Europe, Canada, Japan, US, RoW
Inclisiran sodium 300 mg, Placebo
Novartis Pharmaceuticals
Coronary Artery Disease
01/27
01/27
VICTORION-1 PREVENT, NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Active, not recruiting
3
14013
Europe, Canada, US, RoW
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml
Novartis Pharmaceuticals
Primary Prevention of Atherosclerotic Cardiovascular Disease
04/29
04/29
NCT02737046: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

Active, not recruiting
2
15
US
Belinostat, PXD101, Beleodaq®, Zidovudine, AZT, Interferon-Alfa-2b, IFN-α-2b, Pegylated Interferon-Alfa-2b, PEG-IFN-α-2b
University of Miami
Adult T-cell Leukemia-Lymphoma, ATLL
07/24
07/25
NCT02799485: sEphB4-HSA in Treating Patients With Kaposi Sarcoma

Active, not recruiting
2
23
US
Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Quality of Life Assessment, Recombinant EphB4-HSA Fusion Protein, sEphB4-HSA
AIDS Malignancy Consortium, National Cancer Institute (NCI), Vasgene Therapeutics, Inc, The Emmes Company, LLC, University of Arkansas
Skin Kaposi Sarcoma
12/25
06/26
NCT04305691: Trial of Ixazomib for Kaposi Sarcoma

Recruiting
2
41
US
Ixazomib Citrate, MLN-9708, MLN9708, Ninlaro, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
AIDS Malignancy Consortium, National Cancer Institute (NCI)
Kaposi Sarcoma, Skin
05/25
05/26
MARS-17, NCT05838742: A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain

Active, not recruiting
2
314
Europe, Canada, Japan, US, RoW
GSK3858279, Placebo
GlaxoSmithKline
Pain, Osteoarthritis, Knee
08/24
12/24
Imagine-1, NCT04713475 / 2020-001109-22: Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis

Active, not recruiting
1/2
26
Europe, Canada, US, RoW
PBGM01
Passage Bio, Inc.
GM1 Gangliosidosis, GM1 Gangliosidosis, Type I, GM1 Gangliosidosis, Type 2, Beta-Galactosidase-1 (GLB1) Deficiency
02/26
02/29
AMC-105, NCT04139304: A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Active, not recruiting
1
15
US
Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Daratumumab, Anti-CD38 Monoclonal Antibody, Darzalex, HuMax-CD38, JNJ-54767414, Doxorubicin, Adriablastin, Hydroxydaunomycin, Hydroxyl Daunorubicin, Hydroxyldaunorubicin, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, hydroxydaunorubicin, Rubex, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP-16, VP-16-213, VP16, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Vincristine, LEUROCRISTINE, VCR, Vincrystine, Vincristine Sulfate, Kyocristine, Leurocristine sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
AIDS Malignancy Consortium, National Cancer Institute (NCI), Janssen Scientific Affairs, LLC, Montefiore Medical Center, Memorial Sloan Kettering Cancer Center, AIDS and Cancer Specimen Resource, The Emmes Company, LLC
Plasmablastic Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
07/25
08/27
NCT05321940: Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias

Withdrawn
1
18
NA
STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells, STING (Stimulator of Interferon Genes)-Dependent Activators, STAVs-Loaded Autologous Leukemic Cells, STING-dependent innate immune agonists, Dendritic Cell Vaccine, DC Vaccine
Juan C. Ramos, MD
Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Adult T-Cell Leukemia/Lymphoma
11/25
11/26
OR-ARI-EAP-NPC, NCT04316637: Early Access Program With Arimoclomol in US Patients With NPC

Available
N/A
US
Arimoclomol
ZevraDenmark
Niemann-Pick Disease, Type C
 
 
E²-RADIatE, NCT03818503: E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

Recruiting
N/A
2000
Europe, RoW
European Organisation for Research and Treatment of Cancer - EORTC
Cancer
04/26
04/26
PETIFI, NCT05688592: Usefulness of PET-CT for Invasive Fungal Infection

Recruiting
N/A
224
Europe
PET-CT, Before-and-after study
Puerta de Hierro University Hospital, Gilead Sciences
Invasive Fungal Infections
10/24
12/24
VRAM, NCT03221244: Virtual Reality Attention Management

Recruiting
N/A
50
US
VR Treatment, VR Active Control
University of California, Davis, National Institute of Mental Health (NIMH)
ADHD
09/26
07/27
Hagerman, Randi J
NCT05358886: A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Recruiting
3
150
US
BPN14770/ zatolmilast, Placebo
Tetra Discovery Partners
Fragile X Syndrome
06/25
09/25
RECONNECT, NCT04977986 / 2021-002542-33: Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults with Fragile X Syndrome

Recruiting
3
250
Europe, US, RoW
ZYN002 - transdermal gel, cannabidiol formulated as a clear gel that can be applied to the skin (transdermal delivery), Placebo, Placebo Comparator, Matching Placebo
Zynerba Pharmaceuticals, Inc., Zynerba Pharmaceuticals, Inc.
Fragile X Syndrome
05/25
05/25
NCT03479476: A Trial of Metformin in Individuals With Fragile X Syndrome

Completed
2/3
120
Canada, US
Placebo Medication, Placebo, Metformin, Glumetza, Glucophage, Fortamet, Riomet
University of California, Davis, University of Alberta, St. Justine's Hospital
Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X Linked, Genetic Diseases, X-Linked, Trinucleotide Repeat Expansion, Fra(X) Syndrome, Intellectual Disability, FXS, Neurobehavioral Manifestations, Sex Chromosome Disorders
05/24
05/24
NCT05163808: A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Recruiting
2/3
150
US
zatolmilast, BPN14770, Placebo
Tetra Discovery Partners
Fragile X Syndrome
09/25
12/25
NCT05233579: Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS

Completed
N/A
15
US
Sulforaphane, Avmacol
University of California, Davis
Fragile X Associated Tremor/Ataxia Syndrome (Fxtas) (Diagnosis)
01/23
01/23
Schweitzer, Julie
DelTA, NCT03457402: Shaping Tolerance for Delayed Rewards

Recruiting
N/A
50
US
Shaping Delay Tolerance
University of California, Davis, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Impulsivity
05/25
05/26
NCT04526600: Fidgeting and Attentional and Emotional Regulation in ADHD

Recruiting
N/A
109
US
Fidget ball
University of California, Davis
ADHD
07/24
07/25
VRAM, NCT03221244: Virtual Reality Attention Management

Recruiting
N/A
50
US
VR Treatment, VR Active Control
University of California, Davis, National Institute of Mental Health (NIMH)
ADHD
09/26
07/27
Angkustsiri, Kathleen
DS+ADHD Pilot, NCT04219280: Evaluating Treatment of ADHD in Children with Down Syndrome

Recruiting
4
100
US
Quillivant XR, Placebo
Children's Hospital Medical Center, Cincinnati, University of California, Davis, University of Pittsburgh Medical Center, Boston Children's Hospital, Boston, MA, USA
Down Syndrome, ADHD
09/25
09/25
Solomon, Marjorie
STAAR, NCT03279471: Specifying and Treating Anxiety in Autism Research

Completed
2
68
US
Sertraline, CBT/BIACA, Placebo
University of California, Davis
Autism Spectrum Disorder, Anxiety
02/23
02/23
Heath, Brianna
POTS, NCT05918978: Open Label Extension of Efgartigimod in Adults with Post-COVID-19

Terminated
2
33
US
Efgartigimod
argenx, Iqvia Pty Ltd
Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome
08/24
08/24
NCT05757206: The Syn-Sleep Study

Active, not recruiting
N/A
80
US
Syn-One Test
CND Life Sciences
REM Sleep Behavior Disorder (iRBD)
12/25
12/25
Geng, Joy
VRAM, NCT03221244: Virtual Reality Attention Management

Recruiting
N/A
50
US
VR Treatment, VR Active Control
University of California, Davis, National Institute of Mental Health (NIMH)
ADHD
09/26
07/27
Shickman, Ryan
DelTA, NCT03457402: Shaping Tolerance for Delayed Rewards

Recruiting
N/A
50
US
Shaping Delay Tolerance
University of California, Davis, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Impulsivity
05/25
05/26
Warren, Zachary E
TAP-P, NCT05373173: Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?

Completed
N/A
150
US
Tele-assessment + In-person assessment
Vanderbilt University Medical Center, National Institute of Mental Health (NIMH)
Autism Spectrum Disorder
08/24
08/24
MEASURE-ASD2, NCT05806216: Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD) For Children Ages 31-84 Months

Recruiting
N/A
790
US
EarliPoint Diagnosis, EarliPoint, Clinically Certain Expert Clinician Diagnosis (CC-ECD), CC-ECD
EarliTec Diagnostics, Inc, Marcus Autism Center
Autism Spectrum Disorder, Autism
03/25
03/25
NCT05047224: Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

Recruiting
N/A
720
US
Tele-assessment + in-person assessment, Tele-assessment only
Vanderbilt University Medical Center, National Institute of Mental Health (NIMH)
Autism Spectrum Disorder
12/25
06/26
Miller, Meghan
NCT05903053: Pilot Study: a Telehealth Intervention for Caregivers of Infants with Early Signs of ADHD

Active, not recruiting
N/A
8
US
Early Self-Regulation Intervention
University of California, Davis
Infant Behavior, Infant Development, Self-Control, Self-Regulation, Emotion
10/25
10/25
Ozonoff, Sally
NCT05047224: Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

Recruiting
N/A
720
US
Tele-assessment + in-person assessment, Tele-assessment only
Vanderbilt University Medical Center, National Institute of Mental Health (NIMH)
Autism Spectrum Disorder
12/25
06/26
Gangi, Devon
NCT05047224: Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

Recruiting
N/A
720
US
Tele-assessment + in-person assessment, Tele-assessment only
Vanderbilt University Medical Center, National Institute of Mental Health (NIMH)
Autism Spectrum Disorder
12/25
06/26
Santos, Ellery
NCT05358886: A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Recruiting
3
150
US
BPN14770/ zatolmilast, Placebo
Tetra Discovery Partners
Fragile X Syndrome
06/25
09/25
NCT05163808: A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Recruiting
2/3
150
US
zatolmilast, BPN14770, Placebo
Tetra Discovery Partners
Fragile X Syndrome
09/25
12/25
NCT05233579: Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS

Completed
N/A
15
US
Sulforaphane, Avmacol
University of California, Davis
Fragile X Associated Tremor/Ataxia Syndrome (Fxtas) (Diagnosis)
01/23
01/23
Borden, Jared
LC, NCT06041048: Investigation of Locus Coeruleus Function in Sustained Attention

Recruiting
4
40
US
Modafinil, Provigil
University of California, Davis
Attention - No Condition is Being Assessed - Healthy Adults
08/25
12/25
NCT04526600: Fidgeting and Attentional and Emotional Regulation in ADHD

Recruiting
N/A
109
US
Fidget ball
University of California, Davis
ADHD
07/24
07/25
Gavrilovic, Ema
NCT05301361: Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities

Enrolling by invitation
1
68
US
Methylphenidate Oral Solution
University of California, Davis, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Intellectual Disability, Fragile X Syndrome, Down Syndrome, Attention Deficit Hyperactivity Disorder
09/25
09/26

Download Options